{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:26:15Z","timestamp":1792524375498,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jim.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T06:00:15Z","timestamp":1510120815000},"page":"6-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis"],"prefix":"10.1016","volume":"454","author":[{"given":"Nicole Hartwig","family":"Trier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina Eide","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Heiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Slot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer Tandrup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Houen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2017.11.004_bb0005","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24827","article-title":"Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0010","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0020","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#","article-title":"Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies","volume":"44","author":"Baeten","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0025","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jim.2017.11.004_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/ard.2005.041376","article-title":"Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset","volume":"65","author":"Berglin","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0035","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1373\/clinchem.2007.087569","article-title":"Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins","volume":"53","author":"Bizzaro","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jim.2017.11.004_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","article-title":"Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value","volume":"4","author":"van Boekel","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.jim.2017.11.004_bb0045","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200526000","article-title":"Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis","volume":"35","author":"Burkhardt","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2017.11.004_bb0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","article-title":"Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis","volume":"53","author":"Coenen","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jim.2017.11.004_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12016-007-8030-5","article-title":"Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients","volume":"34","author":"Correia","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jim.2017.11.004_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00365513.2016.1200133","article-title":"The dependency on neighboring amino acids for reactivity of anti-citrullinated protein antibodies to citrullinated proteins","volume":"76","author":"Dam","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jim.2017.11.004_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00002281-200405000-00013","article-title":"Rheumatoid factor revisited","volume":"16","author":"Dorner","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0070","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2005.045229","article-title":"Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis","volume":"65","author":"Elkayam","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8073-2","article-title":"Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: a French multicenter study","volume":"34","author":"Fabien","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jim.2017.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/ard.2004.035089","article-title":"A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis","volume":"64","author":"van Gaalen","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0090","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/art.23681","article-title":"Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making","volume":"58","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0095","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2010.131102","article-title":"Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities","volume":"70","author":"Ioan-Facsinay","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0100","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.23514","article-title":"Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide","volume":"58","author":"Kakumanu","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0105","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3899\/jrheum.090338","article-title":"Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming\/erosive arthritis","volume":"36","author":"Kakumanu","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0110","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jim.2017.11.004_bb0115","article-title":"Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies","volume":"12367","author":"Kogure","year":"2007","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jim.2017.11.004_bb0120","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.24720","article-title":"Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value","volume":"60","author":"Levesque","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cca.2007.08.002","article-title":"Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis","volume":"386","author":"Lutteri","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jim.2017.11.004_bb0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","article-title":"Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease","volume":"46","author":"Machold","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jim.2017.11.004_bb0135","first-page":"542","article-title":"Anti-cyclic citrullinated peptide antibody in systemic sclerosis","volume":"26","author":"Morita","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0140","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.23.4.302","article-title":"A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor","volume":"23","author":"Nienhuis","year":"1964","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0155","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jim.2017.11.004_bb0160","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.131375","article-title":"Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients","volume":"41","author":"Payet","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0165","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","article-title":"Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome","volume":"45","author":"Quinn","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jim.2017.11.004_bb0170","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/00365513.2010.493381","article-title":"Anti-CCP: challenges in quantifying auto-antibodies and creating international reference materials","volume":"242","author":"Rottmann","year":"2010","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.jim.2017.11.004_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10067-007-0656-4","article-title":"A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis","volume":"27","author":"Santiago","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0185","first-page":"2535","article-title":"Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis","volume":"30","author":"Saraux","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2017.11.004_bb0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0200","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2017.11.004_bb0205","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","article-title":"The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies","volume":"95","author":"Sebbag","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2017.11.004_bb0210","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2017.11.004_bb0215","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9343(91)90190-9","article-title":"The rheumatoid factor: an analysis of clinical utility","volume":"91","author":"Shmerling","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jim.2017.11.004_bb0220","first-page":"S35","article-title":"Mortality in rheumatoid arthritis: 2008 update","volume":"26","author":"Sokka","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2e462817-ab93-4d78-95a4-1d8b9d172971","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2017.11.004_bb0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/qjmed\/hcp165","article-title":"Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies","volume":"103","author":"Song","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.jim.2017.11.004_bb0235","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar2449","article-title":"Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project","volume":"10","author":"Sv\u00e4rd","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jim.2017.11.004_bb0240","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12026-013-8425-8","article-title":"Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population","volume":"56","author":"Szekanecz","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jim.2017.11.004_bb0245","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0250","doi-asserted-by":"crossref","first-page":"30709","DOI":"10.1074\/jbc.271.48.30709","article-title":"Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin","volume":"271","author":"Tarcsa","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2017.11.004_bb0255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/antib6010005","article-title":"Epitope specificity of anti-citrullinated protein antibodies","volume":"6","author":"Trier","year":"2017","journal-title":"Antibodies"},{"key":"10.1016\/j.jim.2017.11.004_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2011.12.020","article-title":"Identification of continuous epitopes of HuD antibodies related to paraneoplastic diseases\/small cell lung cancer","volume":"243","author":"Trier","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jim.2017.11.004_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144707","article-title":"Contribution of peptide backbone to anti-citrullinated peptide antibody reactivity","volume":"10","author":"Trier","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2017.11.004_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168542","article-title":"Physical characteristics of a citrullinated pro-filaggrin epitope recognized by anti-citrullinated protein antibodies in rheumatoid arthritis sera","volume":"11","author":"Trier","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2017.11.004_bb0275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.peptides.2016.01.005","article-title":"Application of synthetic peptides for detection of anti-citrullinated peptide antibodies","volume":"76","author":"Trier","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.jim.2017.11.004_bb0280","first-page":"281","article-title":"Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness","volume":"24","author":"del Val del","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jim.2017.11.004_bb0285","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2007.071654","article-title":"Do all anti-citrullinated protein\/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein\/peptide antibody tests in patients with and without rheumatoid arthritis","volume":"67","author":"Vander Cruyssen","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0290","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.22279","article-title":"Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response","volume":"54","author":"Verpoort","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2017.11.004_bb0295","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2017.11.004_bb0300","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2004.02341.x","article-title":"Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis","volume":"135","author":"Vittecoq","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2017.11.004_bb0305","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jim.2017.11.004_bb0310","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1476-4598-12-95","article-title":"Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay","volume":"12","author":"Welner","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jim.2017.11.004_bb0315","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2011-200421","article-title":"The ACPA recognition profile and subgrouping of ACPA-positive RA patients","volume":"71","author":"Willemze","year":"2012","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591730385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591730385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:33:11Z","timestamp":1758299591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217591730385X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":62,"alternative-id":["S002217591730385X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2017.11.004","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}